Literature DB >> 10210872

Quality of life measurements in patients with Parkinson's disease: A community-based study.

.   

Abstract

The objective of this paper is to evaluate the health-related quality of life in a community-based population of patients with Parkinson's disease (PD). The PD population consisted of 233 patients and was derived from a wider prevalence study in the county of Rogaland, Norway. The quality of life was measured by the Nottingham Health Profile (NHP) and four general health and well-being questions. The results were compared with quality of life measurements in 100 patients with diabetes mellitus (DM) and 100 healthy elderly people. The control groups had the same age and sex distribution as the patients with PD. This study showed that PD has a substantial impact on the health-related quality of life. Patients with PD had higher distress scores in all measured dimensions of the NHP than the two control groups. The negative impact of PD was highest for physical mobility, emotional reactions, social isolation and energy. Correlation analysis of the quality of life showed that age, duration of levodopa therapy, higher levodopa doses, depression, cognitive impairment and more advanced disease correlated with higher distress scores in patients with PD. The results of this study showed that PD had a broad impact on well-being, more so than DM. The distress related to the severity of the disease, as well as to depressive symptoms and cognitive impairment. An important finding was the underestimated distress related to lack of energy. Copyright 1998 Lippincott Williams & Wilkins

Entities:  

Year:  1998        PMID: 10210872     DOI: 10.1046/j.1468-1331.1998.550443.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  17 in total

Review 1.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  D Aarsland; K Karlsen
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Health related quality of life in Parkinson's disease: a prospective longitudinal study.

Authors:  K H Karlsen; E Tandberg; D Arsland; J P Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

3.  Risk of sleep-disordered breathing in Parkinson's disease.

Authors:  Wattanachai Chotinaiwattarakul; Praveen Dayalu; Ronald D Chervin; Roger L Albin
Journal:  Sleep Breath       Date:  2010-05-16       Impact factor: 2.816

4.  DTI correlates of distinct cognitive impairments in Parkinson's disease.

Authors:  Zhong Zheng; Shirag Shemmassian; Christopher Wijekoon; Won Kim; Susan Y Bookheimer; Nader Pouratian
Journal:  Hum Brain Mapp       Date:  2013-02-18       Impact factor: 5.038

Review 5.  Sleep disorders in patients with Parkinson's disease: epidemiology and management.

Authors:  J P Larsen; E Tandberg
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 6.  A review of the health-related quality of life and economic impact of Parkinson's disease.

Authors:  Clare H Dowding; Claire L Shenton; Sam S Salek
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

7.  Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease.

Authors:  Amélie C Lanoue; Alexandra Dumitriu; Richard H Myers; Jean-Jacques Soghomonian
Journal:  Exp Neurol       Date:  2010-09-09       Impact factor: 5.330

8.  Neuropsychological functions and rCBF SPECT in Parkinson's disease patients considered candidates for deep brain stimulation.

Authors:  Anna Paschali; Lambros Messinis; Epameinondas Lyros; Costas Constantoyannis; Zinovia Kefalopoulou; Velissarios Lakiotis; Panagiotis Papathanasopoulos; Paulos Vassilakos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-27       Impact factor: 9.236

9.  Declining quality of life in Parkinson disease before and after diagnosis.

Authors:  Natalia Palacios; Xiang Gao; Michael Schwarzschild; Alberto Ascherio
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

10.  Huntington's disease from the patient, caregiver and physician's perspectives: three sides of the same coin?

Authors:  Krzysztof Banaszkiewicz; Emilia J Sitek; Monika Rudzińska; Witold Sołtan; Jarosław Sławek; Andrzej Szczudlik
Journal:  J Neural Transm (Vienna)       Date:  2012-03-08       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.